Lymphocytic choriomeningitis virus-induced mortality in mice is triggered by edema and brain herniation

Christine M Matullo1, Kevin J O'Regan, Harvey Hensley

  • 1Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

Journal of Virology
|October 16, 2009
PubMed

Insights

Lymphocytic choriomori meningitits virus (LCMV) infection in mice causes brain herniation, leading to seizures and death. This neuropathogenesis is not due to blood-brain barrier damage, offering insights into human conditions.

Area of Science:

  • Neurovirology
  • Immunology
  • Pathogenesis

Background:

  • Lymphocytic choriomeningitis virus (LCMV) infection is well-studied in mice, but its central nervous system (CNS) disease mechanisms remain unclear.
  • The characteristic CNS disease following intracerebral LCMV challenge involves seizures and paresis.

Purpose of the Study:

  • To elucidate the underlying basis of LCMV-induced neuropathogenesis and CNS disease.
  • To investigate the role of brain herniation and blood-brain barrier integrity in LCMV infection.

Main Methods:

  • Intracerebral LCMV challenge in adult immunocompetent mice.
  • Water weight determination and magnetic resonance imaging (MRI) for edema detection.
  • Immunohistochemical analysis for inflammation and blood-brain barrier (BBB) integrity.
  • Comparison with perforin knockout mice.

Main Results:

  • LCMV infection led to anatomical and histological changes consistent with uncal brain herniation, causing seizures, paresis, and death.
  • Edema was observed only at terminal stages, likely from cerebrospinal fluid leakage.
  • Periventricular inflammation and BBB disruption preceded seizures but were not the primary cause of neuropathogenesis.
  • BBB permeability in surviving perforin knockout mice was similar to moribund immunocompetent mice.

Conclusions:

  • Uncal brain herniation is the likely cause of death in LCMV-infected mice.
  • Blood-brain barrier damage is not the primary driver of LCMV-induced neuropathogenesis.
  • Understanding LCMV neuropathogenesis may inform therapies for fatal human conditions involving increased intracranial pressure.